• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Unsweetened coffee consumption is associated with reduced risk of mortality

byBryant LimandKiera Liblik
June 21, 2022
in Cardiology, Oncology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Moderate consumption of unsweetened and sugar-sweetened coffee was associated with reduced mortality from cancer and cardiovascular disease as compared to coffee abstinence.

2. Reduction in mortality for unsweetened coffee drinkers was sustained in subgroup analysis across lifestyle and sociodemographic factors.

Evidence Rating Level: 2 (Good)

Study Rundown: Previous observational studies have shown associations between coffee consumption and reduced risk of all-cause mortality. However, there is a paucity of data on the comparative mortality benefit of different types of coffee and the inclusion of sweeteners. The present prospective cohort study used data from the United Kingdom Biobank to evaluate the association between mortality and consumption of unsweetened, sugar-sweetened, and artificially sweetened coffee. Participants were followed for seven years after enrollment. Consumption of unsweetened coffee was associated with reduced risk of all-cause, cancer-specific, and cardiovascular-specific mortality after adjusting for lifestyle, sociodemographic, and clinical factors. Consistent associations between unsweetened coffee with reduced mortality were found for instant, ground, and decaffeinated coffee. Sugar-sweetened coffee was also significantly associated with reduced all-cause and cancer-specific mortality. The study was unable to find conclusive associations between artificially sweetened coffee drinkers and mortality due to the low sample size and statistical power of this group. There are several limitations to cohort studies that may impact the generalizability of these findings. These include self-selection bias of the participants, measurement error related to type and frequency of coffee consumption, and relatively short follow-up time.

Click to read the study in AIM.

Relevant Reading: Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers

RELATED REPORTS

AstraZeneca moves to own multimodal oncology AI with Modella

Lyme disease is associated with significant health care costs

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

In-Depth [prospective cohort]: The present study used data from the United Kingdom Biobank to evaluate the association between unsweetened, sugar-sweetened, and artificially sweetened coffee with mortality. Data on coffee consumption was obtained from a questionnaire that was administered to participants five times over one year about their dietary intake, including coffee, over the previous 24 hours. In the study cohort (n=171,616), 75.8% of participants reported drinking coffee at least one timepoint. Most coffee drinkers consumed unsweetened coffee (55%), followed by sugar (14%), and artificially (6%) sweetened coffee. The median follow-up time was seven years (interquartile range, 6.6 to 7.8). There was a significant U-shaped association between unsweetened coffee and sugar-sweetened coffee with all-cause mortality (p<0.001). The most beneficial effects are seen with moderate coffee consumption with increasingly harmful effects with excessive consumption. For unsweetened coffee, consumption of any amount was associated with a reduced risk of all-cause mortality after adjusting for lifestyle, sociodemographic, and clinical factors. Artificially sweetened coffee was not associated with improvements in risk for all-cause mortality. There was also a significant U-shaped association between unsweetened coffee and cancer and cardiovascular mortality (p<0.001). Moderate consumption of sugar and artificially sweetened coffee were weakly associated with lower cancer mortality. In summary, this study suggested potential health benefits associated with consuming unsweetened coffee compared to sugar or artificially sweetened coffee.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: caffienecancercardiovascular diseasecardiovascular preventioncoffeemortalityoncologypreventionpublic healthsweetener
Previous Post

ANNEXA-A and ANNEXA-R trials: Andaxanet Alfa for Reversal of Apixaban and Rivaroxaban [Classics Series]

Next Post

Ustekinumab and adalimumab comparable in safety and efficacy for treatment of Crohn’s disease

RelatedReports

Patients with advanced adenomas are at increased risk of developing colorectal cancer
AI Roundup

AstraZeneca moves to own multimodal oncology AI with Modella

January 21, 2026
Longer duration of antibiotic therapy does not reduce persistent symptoms in Lyme disease
Infectious Disease

Lyme disease is associated with significant health care costs

January 19, 2026
2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

January 19, 2026
Testosterone replacement in male cancer survivors helps improve body composition
Oncology

New model enhances prediction of prostate cancer-specific mortality

January 12, 2026
Next Post
Thalidomide may be effective in refractory pediatric Crohn’s disease

Ustekinumab and adalimumab comparable in safety and efficacy for treatment of Crohn’s disease

Estrogen withdrawal associated with perimenopausal depression

Accelerated approval drugs incur significant fee-for-service Medicare costs

Children’s hospital visits for suicide ideation and attempts are increasing

Islamic-based interventions may improve both depression and anxiety

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Duloxetine is effective in refractory chronic cough
  • AstraZeneca moves to own multimodal oncology AI with Modella
  • Cast immobilization is non-inferior to surgical intervention in isolated Weber B fractures of lateral malleolus
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.